A significant inhibitory effect of Selinexor on AR-dependent and -independent PCa tumor growth was observed both in vivo and ex vivo, suggesting that XPO1 blockade can repress both AR and other oncogenic pathway-mediated PCa growth. The gene discussed is XPO1; the disease is neoplasm.